MAXCYTE INC. - COMMON
3,8800
08-октября-24 15:59:58
15 мин. задержка
Акции
+0,1000
+2,65%
Сегодняшний диапазон
3,7500 - 3,8900
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
MaxCyte Reports Third Quarter 2022 Financial Results
09 ноя 2022 16:05:03 Источник Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
02 ноя 2022 08:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte to Report Third Quarter 2022 Financial Results on November 9, 2022
12 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
28 сен 2022 08:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor
21 сен 2022 08:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
07 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results
10 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2022 Financial Results on August 10, 2022
15 июл 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Signs Strategic Platform License with LG Chem to Advance its Allogeneic CAR-T Programs
12 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 май 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Reports First Quarter Financial Results
09 май 2022 16:05:03 Источник Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
03 май 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
MaxCyte to Report First Quarter 2022 Financial Results on May 9, 2022
20 апр 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 апр 2022 09:00:00 Источник Nasdaq GlobeNewswire
-
12 апр 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year Financial Results
22 мар 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer
09 мар 2022 16:15:00 Источник Nasdaq GlobeNewswire
-
MaxCyte to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022
24 фев 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
14 фев 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 фев 2022 17:00:00 Источник Nasdaq GlobeNewswire